Briaud Financial Planning »

Sarepta Therapeutics shares owned by Briaud Financial Planning

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Briaud Financial Planning from 13F filings

Historical chart of Briaud Financial Planning investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Briaud Financial Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Briaud Financial Planning

Quarter filed Position value Share count Share price at filing
2025-06-30 $999 90 11.11

More positions owned by Briaud Financial Planning

Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Gold Tr Gold Shs (GLD)
Invesco Actvely Mngd Etc Optimum Yield (PDBC)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Silver Tr Ishares (SLV)
Ishares Gold Tr Ishares New (IAU)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Analog Devices (ADI)
Exxon Mobil Corporation (XOM)
Abrdn Platinum Etf Trust Physcl Platm Shs (PPLT)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)

View all positions for Briaud Financial Planning

Top funds holding Sarepta Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Susquehanna International
Erste Asset Management GmbH
Renaissance Technologies
Two Sigma Investments
D. E. Shaw & Co
UBS Group
Standard Life Aberdeen
Two Sigma Advisers
First Trust Advisors
Citadel Advisors
Bnp Paribas Arbitrage, Snc
Connor, Clark & Lunn Investment Management

View all funds holding Sarepta Therapeutics